Evidence map›Paper›PMID 38036259›Full record

ArticleInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2024

Long-term non-progression and risk factors for disease progression among children living with HIV in Botswana and Uganda: A retrospective cohort study.

Samuel Kyobe, Grace Kisitu, Savannah Mwesigwa, John Farirai, Eric Katagirya, Gaone Retshabile, Lesedi Williams, Angela Mirembe, Lesego Ketumile, Misaki Wayengera and 24 more

Open access · goldAbstract read
In one paragraph

Article in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Predictors of Treatment Failure in Children With HIV Starting First-line Antiretroviral Therapy in the ODYSSEY Trial.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Trial
  2. Article
  3. BeyondFrontiers in genetics · 2026
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors at 9 institutions in 4 countries.

Samuel KyobeDepartment of Medical Microbiology, College of Health Sciences, Makerere University, Kampala, Uganda. Electronic address: samuelkyobe@gmail.com.
Grace KisituBaylor College of Medicine Children's Foundation Uganda, Kampala, Uganda.
Savannah MwesigwaDepartment of Medical Microbiology, College of Health Sciences, Makerere University, Kampala, Uganda.
John FariraiBotswana-Baylor Children's Clinical Centre of Excellence, Gaborone, Botswana.
Eric KatagiryaDepartment of Immunology and Molecular Biology, College of Health Sciences, Makerere University, Kampala, Uganda.
Gaone RetshabileDepartment of Biological Sciences, University of Botswana, Gaborone, Botswana.
Lesedi WilliamsDepartment of Biological Sciences, University of Botswana, Gaborone, Botswana.
Angela MirembeBaylor College of Medicine Children's Foundation Uganda, Kampala, Uganda.
Lesego KetumileBotswana-Baylor Children's Clinical Centre of Excellence, Gaborone, Botswana.
Misaki WayengeraDepartment of Immunology and Molecular Biology, College of Health Sciences, Makerere University, Kampala, Uganda.
John MukisaDepartment of Immunology and Molecular Biology, College of Health Sciences, Makerere University, Kampala, Uganda.
Gaseene SebetsoDepartment of Biological Sciences, University of Botswana, Gaborone, Botswana.
Thabo DiphokoDepartment of Biological Sciences, University of Botswana, Gaborone, Botswana.
Marion AmujalDepartment of Immunology and Molecular Biology, College of Health Sciences, Makerere University, Kampala, Uganda.
Edgar KigoziDepartment of Immunology and Molecular Biology, College of Health Sciences, Makerere University, Kampala, Uganda.
Fred KatabaziDepartment of Immunology and Molecular Biology, College of Health Sciences, Makerere University, Kampala, Uganda.
Ronald OcengBaylor College of Medicine Children's Foundation Uganda, Kampala, Uganda.
Busisiwe MlotshwaDepartment of Biological Sciences, University of Botswana, Gaborone, Botswana.
Koketso MorapediDepartment of Biological Sciences, University of Botswana, Gaborone, Botswana.
Betty NsangiBaylor College of Medicine Children's Foundation Uganda, Kampala, Uganda.
Edward WampandeDepartment of Immunology and Molecular Biology, College of Health Sciences, Makerere University, Kampala, Uganda.
Masego TsimakoAustralian Medical Research, Hurstville, Australia.
Chester BrownUniversity of Tennessee Health Science Center, Memphis, USA.
Ishmael KasvosveSchool of Allied Health Professionals, Faculty of Health Sciences, University of Botswana, Gaborone, Botswana.
Moses JolobaDepartment of Immunology and Molecular Biology, College of Health Sciences, Makerere University, Kampala, Uganda.
Gabriel AnabwaniBaylor College of Medicine Children's Foundation Uganda, Kampala, Uganda.
Sununguko MpolokaDepartment of Biological Sciences, University of Botswana, Gaborone, Botswana.
Graeme MardonDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, USA; Department of Pathology and Immunology, Baylor College of Medicine, Houston, USA.
Adeodata KekitiinwaBaylor College of Medicine Children's Foundation Uganda, Kampala, Uganda; Pediatric Retrovirology, Department of Pediatrics, Baylor College of Medicine, Houston, USA.
Neil A HanchardDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, USA; USDA/ARS/Children's Nutrition Research Center, Baylor College of Medicine, Houston, USA; Childhood Complex Disease Genomics Section, Center for Precision Health Research, National Human Genome Research Institute, National Institutes of Health, Bethesda, USA.
Jacqueline Kyosiimire-LugemwaUganda Virus Research Institute, Entebbe, Uganda.
Mogomotsi MatshabaBotswana-Baylor Children's Clinical Centre of Excellence, Gaborone, Botswana; Pediatric Retrovirology, Department of Pediatrics, Baylor College of Medicine, Houston, USA.
Dithan KiraggaBaylor College of Medicine Children's Foundation Uganda, Kampala, Uganda; Pediatric Retrovirology, Department of Pediatrics, Baylor College of Medicine, Houston, USA.
Collaborative African Genomics Network (CAfGEN) of the H3Africa Consortium
Makerere University · UGUniversity of Botswana · BWBaylor College of Medicine Children’s Foundation · UGBaylor College of Medicine · USBotswana-Baylor Children's Clinical Center of Excellence · BWNational Institutes of Health · USSouth Australian Health and Medical Research Institute · AUUganda Virus Research Institute · UGUniversity of Tennessee Health Science Center · US

Funding

Phenotyping and BioarchivingU54AI110398 · NIAID · BOTSWANA BAYLOR CHILD/CLINCAL CTR/EXCELL · PI MATSHABA, MOGOMOTSI SANDY · 2014 to 2021
$8.9M
NIAID NIH HHS U54 AI110398Wellcome Trust
6 · The paper itself

Abstract

objectivesWe utilize a large retrospective study cohort derived from electronic medical records to estimate the prevalence of long-term non-progression (LTNP) and determine the factors associated with progression among children infected with HIV in Botswana and Uganda.

methodsElectronic medical records from large tertiary HIV clinical centers in Botswana and Uganda were queried to identify LTNP children 0-18 years enrolled between June 2003 and May 2014 and extract demographic and nutritional parameters. Multivariate subdistribution hazard analyses were used to examine demographic factors and nutritional status in progression in the pre-antiretroviral therapy era.

resultsBetween the two countries, 14,246 antiretroviral therapy-naïve children infected with HIV were enrolled into clinical care. The overall proportion of LTNP was 6.3% (9.5% in Botswana vs 5.9% in Uganda). The median progression-free survival for the cohort was 6.3 years, although this was lower in Botswana than in Uganda (6.6 vs 8.8 years; P <0.001). At baseline, the adjusted subdistribution hazard ratio (aHR

conclusionsIn our study, the prevalence of pediatric LTNP was lower than that observed among adult populations, but progression-free survival was higher than expected. Underweight, year of enrollment into care, and country of origin are independent predictors of progression among children.

Indexed as

HIV InfectionsThinnessAdultBotswanaChildDisease ProgressionHumansRetrospective StudiesRisk FactorsUgandaAfricaHIV progressionLTNPPediatric

Identifiers

PMID38036259
PMCPMC10843817
OpenAlexW4389100966

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.